Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Chile Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20113
20132
20141
20152
20161
20172
20182
20191
20212
20222
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated6
Active, not recruiting4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Genentech, Inc.2
MedImmune LLC2
Ablynx, a Sanofi company1
Alumis Inc1
AstraZeneca1
Beeline Medicines Corporation1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic24
Autoimmune Diseases4
Connective Tissue Diseases3
Immune System Diseases2
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Lupus Nephritis1
Mycobacterium Infections, Nontuberculous1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.